PROBABILISTIC LEARNING OF TREATMENT TREES IN CANCER
Tsung-Hung Yao1, Zhenke Wu1, Karthik Bharath2
1Department of Biostatistics, University of Michigan at Ann Arbor.
Abstract:
Accurate identification of synergistic treatment combinations and their underlying biological mechanisms is critical across many disease domains, especially cancer. In translational oncology research, preclinical systems such as patient-derived xenografts (PDX) have emerged as a unique study design evaluating multiple treatments administered to samples from the same human tumor implanted into genetically identical mice. In this paper, we propose a novel Bayesian probabilistic tree-based framework for PDX data to investigate the hierarchical relationships between treatments by inferring treatment cluster trees, referred to as treatment trees (Rx-tree). The framework motivates a new metric of mechanistic similarity between two or more treatments accounting for inherent uncertainty in tree estimation; treatments with a high estimated similarity have potentially high mechanistic synergy. Building upon Dirichlet Diffusion Trees, we derive a closed-form marginal likelihood encoding the tree structure, which facilitates computationally efficient posterior inference via a new two-stage algorithm. Simulation studies demonstrate superior performance of the proposed method in recovering the tree structure and treatment similarities. Our analyses of a recently collated PDX dataset produce treatment similarity estimates that show a high degree of concordance with known biological mechanisms across treatments in five different cancers. More importantly, we uncover new and potentially effective combination therapies that confer synergistic regulation of specific downstream biological pathways for future clinical investigations. Our accompanying code, data, and shiny application for visualization of results are available at: https://github.com/bayesrx/RxTree.
Insights
This study introduces a new Bayesian framework to analyze patient-derived xenograft (PDX) data, identifying synergistic cancer treatment combinations and their mechanisms. The method reveals potential new therapies by estimating mechanistic similarity between treatments.
Area of Science:
- Oncology
- Computational Biology
- Biostatistics
Background:
- Identifying synergistic cancer treatments and their mechanisms is crucial for effective therapy.
- Patient-derived xenografts (PDX) offer a valuable preclinical model for evaluating multiple treatment combinations on human tumor samples.
- Existing methods lack robust frameworks for analyzing complex relationships within PDX data.
Purpose of the Study:
- To propose a novel Bayesian probabilistic tree-based framework (Rx-tree) for analyzing PDX data.
- To infer hierarchical treatment relationships and quantify mechanistic similarity between treatments.
- To identify potential synergistic treatment combinations for cancer therapy.
Main Methods:
- Developed a Bayesian probabilistic tree-based framework (Rx-tree) utilizing Dirichlet Diffusion Trees.
- Derived a closed-form marginal likelihood for computationally efficient posterior inference using a two-stage algorithm.
- Introduced a new metric for mechanistic similarity between treatments, accounting for estimation uncertainty.
Main Results:
- The proposed Rx-tree framework accurately recovers treatment structures and similarities in simulation studies.
- Analysis of a PDX dataset showed high concordance between estimated treatment similarities and known biological mechanisms across five cancer types.
- Identified novel, potentially effective combination therapies with synergistic pathway regulation.
Conclusions:
- The Rx-tree framework provides a robust and computationally efficient method for analyzing PDX data.
- This approach facilitates the discovery of synergistic treatment combinations and elucidation of their underlying biological mechanisms.
- The findings offer promising avenues for future clinical investigations in cancer therapy.
More Related Videos
Related Concept Videos
Survival Tree
Building a Survival Tree
Constructing a...
Cancer Survival Analysis
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Treatment Resistant Cancers
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Hazard Ratio
For example, in a clinical trial...


